The Food and Drug Administration (FDA) is reopening until April 27, 2004, the comment period on the draft guidance for industry entitled ``Marketing Unapproved Drugs; Compliance Policy Guide.'' The agency announced the availability of this draft...
Due of Comment: 4/27/2004 Published Date: 2/27/2004 Pages: 9340-9340 (1 pages)